Repro Med Systems Stock Performance

KRMD Stock  USD 5.72  0.33  6.12%   
On a scale of 0 to 100, Repro Med holds a performance score of 13. The company holds a Beta of 0.27, which implies not very significant fluctuations relative to the market. As returns on the market increase, Repro Med's returns are expected to increase less than the market. However, during the bear market, the loss of holding Repro Med is expected to be smaller as well. Please check Repro Med's treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to make a quick decision on whether Repro Med's historical price patterns will revert.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Repro Med Systems are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Repro Med exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
(1.10)
Five Day Return
(5.93)
Year To Date Return
(3.92)
Ten Year Return
1.1 K
All Time Return
4.8 K
1
KORU Medical Systems, Inc. Reports Q3 Loss, Tops Revenue Estimates
11/12/2025
2
KORU Medical Systems, Inc. Q3 2025 Earnings Call Transcript
11/14/2025
3
KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE Syringe Infusion System in Infusion Centers at ESIDEHASIOPE Focused Symposium 20...
11/17/2025
4
Disposition of 41000 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3
11/26/2025
5
Koru Medical names Eric Schiller CTO - TipRanks
12/16/2025
6
Heres Why You Should Retain INSP Stock in Your Portfolio Now
12/22/2025
7
Insider Trading
12/29/2025
8
Acquisition by Manko Joseph M. Jr. of 2581 shares of Repro Med subject to Rule 16b-3
12/31/2025
9
Acquisition by Fletcher R John of 3872 shares of Repro Med at 5.81 subject to Rule 16b-3
01/02/2026
10
KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results Achieves Record Revenue and Full Year Positive Operating Cash Flow
01/12/2026
11
KORU Medical Systems Receives FDA 510 Clearance for Delivery of RYSTIGGO , Expanding Label for FreedomEDGE Infusion System
01/29/2026
Begin Period Cash Flow11.5 M
Total Cashflows From Investing Activities-1.3 M

Repro Med Relative Risk vs. Return Landscape

If you would invest  386.00  in Repro Med Systems on November 4, 2025 and sell it today you would earn a total of  153.00  from holding Repro Med Systems or generate 39.64% return on investment over 90 days. Repro Med Systems is currently generating 0.6148% in daily expected returns and assumes 3.7319% risk (volatility on return distribution) over the 90 days horizon. In different words, 33% of stocks are less volatile than Repro, and 88% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Repro Med is expected to generate 5.02 times more return on investment than the market. However, the company is 5.02 times more volatile than its market benchmark. It trades about 0.16 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of risk.

Repro Med Target Price Odds to finish over Current Price

The tendency of Repro Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 5.72 90 days 5.72 
about 27.01
Based on a normal probability distribution, the odds of Repro Med to move above the current price in 90 days from now is about 27.01 (This Repro Med Systems probability density function shows the probability of Repro Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Repro Med has a beta of 0.27. This indicates as returns on the market go up, Repro Med average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Repro Med Systems will be expected to be much smaller as well. Additionally Repro Med Systems has an alpha of 0.4483, implying that it can generate a 0.45 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Repro Med Price Density   
       Price  

Predictive Modules for Repro Med

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Repro Med Systems. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
1.735.469.19
Details
Intrinsic
Valuation
LowRealHigh
2.396.129.85
Details
Naive
Forecast
LowNextHigh
1.495.228.95
Details
5 Analysts
Consensus
LowTargetHigh
6.016.607.33
Details

Repro Med Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Repro Med is not an exception. The market had few large corrections towards the Repro Med's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Repro Med Systems, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Repro Med within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.45
β
Beta against Dow Jones0.27
σ
Overall volatility
0.80
Ir
Information ratio 0.12

Repro Med Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Repro Med for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Repro Med Systems can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Repro Med Systems appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 33.65 M. Net Loss for the year was (6.07 M) with profit before overhead, payroll, taxes, and interest of 24.35 M.
Repro Med Systems currently holds about 18.27 M in cash with (319.72 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41.
Roughly 56.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: KORU Medical Systems Receives FDA 510 Clearance for Delivery of RYSTIGGO , Expanding Label for FreedomEDGE Infusion System

Repro Med Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Repro Stock often depends not only on the future outlook of the current and potential Repro Med's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Repro Med's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding45.8 M
Cash And Short Term Investments9.6 M

Repro Med Fundamentals Growth

Repro Stock prices reflect investors' perceptions of the future prospects and financial health of Repro Med, and Repro Med fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Repro Stock performance.

About Repro Med Performance

By analyzing Repro Med's fundamental ratios, stakeholders can gain valuable insights into Repro Med's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Repro Med has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Repro Med has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 95.56  176.79 
Return On Tangible Assets(0.26)(0.25)
Return On Capital Employed(0.29)(0.28)
Return On Assets(0.26)(0.24)
Return On Equity(0.32)(0.31)

Things to note about Repro Med Systems performance evaluation

Checking the ongoing alerts about Repro Med for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Repro Med Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Repro Med Systems appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 33.65 M. Net Loss for the year was (6.07 M) with profit before overhead, payroll, taxes, and interest of 24.35 M.
Repro Med Systems currently holds about 18.27 M in cash with (319.72 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41.
Roughly 56.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: KORU Medical Systems Receives FDA 510 Clearance for Delivery of RYSTIGGO , Expanding Label for FreedomEDGE Infusion System
Evaluating Repro Med's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Repro Med's stock performance include:
  • Analyzing Repro Med's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Repro Med's stock is overvalued or undervalued compared to its peers.
  • Examining Repro Med's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Repro Med's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Repro Med's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Repro Med's stock. These opinions can provide insight into Repro Med's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Repro Med's stock performance is not an exact science, and many factors can impact Repro Med's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Repro Stock analysis

When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stocks Directory
Find actively traded stocks across global markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Transaction History
View history of all your transactions and understand their impact on performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like